Pure Global

EXPANSORES TISULARES - INVIMA Registration 57fe7dec76268e2e72a5dfb3f6cfc65f

Access comprehensive regulatory information for EXPANSORES TISULARES (TISSUE EXPANDERS) in the Colombia medical device market through Pure Global AI's free database. This IIb medical device is registered under INVIMA analysis ID 57fe7dec76268e2e72a5dfb3f6cfc65f and manufactured by JOHNSON & JOHNSON DE COLOMBIA S.A.. The device was registered on October 29, 2031.

This page provides complete registration details including product type (SURGICAL DOCTOR), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
IIb
57fe7dec76268e2e72a5dfb3f6cfc65f
EXPANSORES TISULARES
INVIMA Analysis ID: 57fe7dec76268e2e72a5dfb3f6cfc65f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

INDICACIONES Y USOS: RECONSTRUCCIร“N MAMARIA POST MASTECTOMIA, CORRECCION DE MAMA POCO DESARROLLADA Y REVISIร“N DE CICATRICES Y DEFECTOS TISULARES LOS DISPOSITIVOS ESTAN INDICADOS PARA IMPLANTACIร“N SUBCUTรNEA O SUBMUSCULAR TEMPORAL Y NO SE ESPERA QUE SU USO SOBREPASE LOS SEIS MESES.

English

INDICATIONS AND USES: POST-MASTECTOMY BREAST RECONSTRUCTION, UNDERDEVELOPED BREAST CORRECTION AND REVISION OF SCARS AND TISSUE DEFECTS THE DEVICES ARE INDICATED FOR TEMPORARY SUBCUTANEOUS OR SUBMUSCULAR IMPLANTATION AND THEIR USE IS NOT EXPECTED TO EXCEED SIX MONTHS.

Device Classification
Risk Class / Clase de Riesgo
IIb
Product Type (Spanish)
MEDICO QUIRURGICOS
Product Type (English)
SURGICAL DOCTOR
Registration Information
Analysis ID
57fe7dec76268e2e72a5dfb3f6cfc65f
Expire Date
October 29, 2031
Authorized Company / Fabricante
Name (English)
JOHNSON & JOHNSON DE COLOMBIA S.A.